Korea Investment Partners
VC Fund
Seoul, South Korea
Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.
- Total investments:
- 538
- Last investment:
- Lead investor:
- 26%
- Fund size:
- $60M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Korea Investment Partners invests in
Stages Korea Investment Partners invests in
Countries Korea Investment Partners invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 24 contacts → | |||
Round size
- Seed
- $973k–$10M
- Series A
- $2.2M–$19M
- Series B
- $4.9M–$50M
Investment Focus
Industry
- Biotechnology 63 (12%)
- Health Care 60 (11%)
- Information Technology 58 (11%)
- Medical 53 (10%)
- Software 51 (9%)
Stage
- Series A 171 (32%)
- Series B 144 (27%)
- Seed 76 (14%)
- Series C 41 (8%)
- Venture - Series Unknown 32 (6%)
Country
- South Korea 266 (49%)
- United States 44 (8%)
- China 32 (6%)
- Israel 8 (1%)
- Singapore 8 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Deok Joon Shin
Director
|
Director | Total investments: 1 | Find email | |
Dong Yeob Kim
Executive Director & Chief Investment Officer
|
Executive Director & Chief Investment Officer | Total investments: 0 | Find email | |
Kun Ho Kim
Principal
|
Principal | Total investments: 1 | Find email | |
Min Q Kim
Director
|
Director | Total investments: 2 | Find email | |
Richard Cui
Director
|
Director | Total investments: 0 | Find email | |
| See all 24 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics. | $13.5M / Series B / Sep 28, 2026 | ||
| Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable ofprocessing large amounts of data.The company was founded in 2021 and is based in New York. | $250M / Series D / Sep 24, 2026 | ||
| heXem bio specializes in recording solutions for the early development of humans for longevity. | Seed / Sep 15, 2026 | ||
| MVRIX is a forward-thinking biotechnology company that focuses on pushing the boundaries of therapeutic innovation. The company specialises in developing new drugs based on platform technology related to membranes and viruses, enabling humans to be free from the attack of viruses and microorganisms. Additionally, it offers engineerable recombinantbotulinum toxin and virucidal therapeutics. | $5.9M / Series B / Sep 04, 2026 | ||
| TwelveLabs develops artificial intelligence models and infrastructure for understanding, searching, and analyzing video content. Its platform enables applications to interpret visual, audio, and spoken information within videos, allowing users to perform semantic search, generate summaries, identify events and objects, and extract insights fromvideo data. The company provides APIs and multimodal AI models that support use cases across media, entertainment, security, enterprise knowledge management, and other video-intensive applications. It also conducts research in video understanding and machine learning to improve how AI processes and reasons over video content. | $100M / Series B / Jul 01, 2026 | ||
| Xpanner(Builtworlds Top 50), digital contech site solution, not only can bring productivity improvement(by 15% average), management efficency, safety and ESG improvement through our smart integration of conTech disparate products. | $18M / Series B / May 14, 2026 | ||
| GGWP provides a gaming tool to help reduce toxic and disruptive in the game. | $15M / Series A / Apr 30, 2026 | ||
|
All My Anic Dots
|
All My Anic Dots is a virtual entertainment company dedicated to the creation, development, and management of virtual idols—digital performers brought to life through advanced animation, motion capture, and artificial intelligence technologies. | $4.7M / Seed / Apr 23, 2026 | |
| FairSquare Labs offers services for digital asset management and Web 3. Blockchain innovations like the security token mainnet, multi-signature and MPC wallets, de-fi, and dex were created by them. They also mine, stake, trade, and fund crypto venture capital initiatives as well. They believe that the strength of their team places us in a uniqueposition to bridge the gap between traditional and digital assets. | Series B / Apr 15, 2026 | ||
| Q‑Factor is building the physical infrastructure needed to scale quantum computing. They design neutral‑atom quantum systems from the ground up to support millions of qubits.They target the key bottlenecks of control, connectivity, and error correction between today’s prototypes and commercially viable quantum machines. | $24M / Seed / Apr 06, 2026 | ||
| See all 538 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Korea Investment Partners invest in?
Korea Investment Partners invests primarily in Biotechnology, Health Care and Information Technology startups, most often at Series A and Series B stage. Most of the 538 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Korea Investment Partners's check size?
Korea Investment Partners typically joins rounds of $973k–$10M at Seed, $2.2M–$19M at Series A and $4.9M–$50M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Korea Investment Partners participates in.
How do I contact Korea Investment Partners?
Public channels for Korea Investment Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Korea Investment Partners?
The team at Korea Investment Partners includes Deok Joon Shin (Director), Dong Yeob Kim (Executive Director & Chief Investment Officer) and Kun Ho Kim (Principal), among 24 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
